7th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (September 1st, 2020).
Cumulative number of infections per 100,000 people for one week (August 25 to 31): 4.13 (5,209↓) nationwide, 9.98 (1,389↓) in Tokyo, 4.05 (306↓) in Aichi, 7.36 (648↓) in Osaka, 8.41 (429↓) in Fukuoka, and 15.97 (232↓) in Okinawa
Rate of cases of unknown infection route (August 22 to 28): 50.8% (0.1%↓ from previous week) nationwide, 59.5% (2.4%↓) in Tokyo
9th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (September 24, 2020). Document 3
Concerning the number of patients with severe disease, the criteria for targets differ from those published on August 14 or earlier. ↑ represents an increase from the previous week, and ↓ represents a decrease.
*Concerning the number of patients with severe disease, the criteria for the targets differ from those published from September 16. The figures in parentheses represent comparison with the same criteria for the previous week.
*Numbers of tests between 9/14 and 20 are provisional, and do not include some results obtained from private laboratories and medical institutions. The rates of positive test results are also provisional since these figures were obtained by dividing the number of positive patients by the number of tests.
Number of new infections (per 100,000 people) etc. (PDF)
Current Situation of COVID-19 Infection.
5th meeting of the COVID-19 advisory board of Ministry of Health, Labour and Welfare (August 6th, 2020).
Nationwide: 7.33 (9,248), Tokyo: 17.41 (2,424), Aichi: 14.38 (1,086), Osaka: 14.37 (1,266),
Fukuoka: 16.58 (846), Okinawa: 30.32 (439)
Nationwide: 52%, Tokyo: 59%
Osaka: 534 (42%), Fukuoka: 183 (37%), Okinawa: 83 (37%)
Osaka: 13 (7%), Fukuoka: 5 (8%), Okinawa: 2 (5%)
Osaka: 11,287 (+42%), Fukuoka: 10,312 (+95%), Okinawa: 3,433 (+143%)
Aichi: 18.5% (+3% points), Osaka: 11.1% (+1.4% points), Fukuoka: 7.4% (-0.3% points), Okinawa: 9.5% (+6.6% points)
*Mid-April (from April 13 through 19): Nationwide: 7.6, Tokyo: 9.0
Posted date 2020/6/3
In this report, we describe an outbreak of novel coronavirus disease (COVID-19) that occurred on the cruise ship, “Costa Atlantica”, docked in Nagasaki City, Nagasaki Prefecture. This report provides information pertaining to the confirmation of a cluster of COVID-19 cases, the initial test results, and the early situation on the ship. Response activities are currently ongoing, and this report should be considered as preliminary and interim.
On 29 January 2020, the Italian cruise ship, “Costa Atlantica”, entered Nagasaki Port and docked inside the port on 20 February, remaining there until 25 March for ship repairs. Since then, given the enhanced quarantine measures implemented globally, departure became difficult and the ship continued to remain in Nagasaki Port. All persons on the ship were crew members, with 623 persons on board on 20 April 2020. Many were young male adults; 523 (84%) were men with a median age of 31 years (range: 19-69 years). The majority were of foreign nationality, with the Philippines, India, Indonesia, and China (listed in descending order) contributing the largest number of crew members.
Posted date 2020/4/9
On February 1, 2020, novel coronavirus infectious disease (COVID-19) was added as a designated infectious disease under the Infectious Diseases Control Law, article 6 in paragraph 8, requiring physicians to immediately report diagnosed novel coronavirus infection cases to the public health center in their jurisdiction. Additionally, active epidemiological investigation became possible, as stipulated in the Infectious Diseases Control Law, article 15.
The primary sources of data in this report were lab-confirmed novel coronavirus infection cases (including asymptomatic SARS-CoV-2 infection cases) reported through both the National Epidemiological Surveillance of Infectious Diseases (NESID) system and the active epidemiological investigation program, as of March 23. Cases reported by local public health centers through NESID were linked to cases monitored daily for follow-up by members of the Novel Coronavirus Response Headquarters team at the Ministry of Health, Labour and Welfare (MHLW), via the active epidemiological investigation program. This report provides an update to the previous report for the data as of March 9 (https://www.niid.go.jp/niid/en/2019-ncov-e/2484-idsc/9497-covid19-14-200309-e.html), and is the third update thus far. As data collection is ongoing, the data may be revised or updated accordingly in the future. It should also be noted that there is delayed reporting or cases still in the process of notification for some cases. As such, there may be a difference in the number of cases in this report versus those officially reported by MHLW. It is expected that this difference will be gradually resolved in the future, but caution is required.
Posted date 2020/3/17
On February 1, 2020, new coronavirus infectious disease (COVID-19) was added as a designated infectious disease under the Infectious Diseases Control Law, article 6 in paragraph 8, which required doctors to immediately report diagnosed COVID-19 cases to the public health center in their jurisdiction. These reported cases were aggregated through the national epidemiological surveillance of infectious diseases (NESID) system. Additionally, active epidemiological investigation could then be conducted, as stipulated in the Infectious Diseases Control Law, article 15.
The primary sources of data in this report were lab-confirmed COVID-19 cases reported through NESID and active epidemiological investigations, as of March 9. Data in NESID were aggregated from reporting by local public health centers. Daily data in active epidemiological investigation by local public health centers were aggregated by teams from the Novel Coronavirus Response Headquarters at the Ministry of Health, Labor, and Welfare (MHLW). This updated report provides additions to the report published on February 24 (https://www.niid.go.jp/niid/en/2019-ncov-e/2484-idsc/9473-2019-ncov-08-e-2.html). As data collection is ongoing, this report may be revised or updated accordingly in the future. It should also be noted that there are cases in which there may have been delayed reporting or case notification not yet completed. As such, there may be a difference in the number of cases reviewed in this report versus those under active investigation by MHLW. It is expected that this difference will be resolved in the future, but please note that there may be a difference.
On February 1, 2020, the novel coronavirus infectious disease (COVID-19) was added as a designated infectious disease under the Infectious Diseases Control Law, article 6 in paragraph 8, which requires doctors to immediately report diagnosed COVID-19 cases to the public health center in their jurisdiction. These reported cases are aggregated through the national epidemiological surveillance of infectious diseases (NESID) system. Additionally, active epidemiological investigation can be conducted, as stipulated in the Infectious Diseases Control Law, article 15.
The primary sources of data in this report were lab-confirmed COVID-19 cases notified through NESID and active epidemiological investigations, as of February 24. Data in NESID are aggregated from reporting by local public health centers. Daily data in active epidemiological investigation by local public health centers were aggregated by teams from the Novel Coronavirus Response Headquarters at the Ministry of Health, Labor, and Welfare (MHLW). As data collection is ongoing, this report may be revised or updated accordingly in the future. It should also be noted that there are cases in which there may be delayed reporting or case notification has not been completed. As such, there may be a difference in the number of cases reviewed in this report versus those under active investigation by MHLW. It is expected that this difference will be resolved in the future, but please note that there may be a difference.
February 27, 2020 | Manual for Active Epidemiological Surveillance of Patients with Novel Coronavirus Infection (Provisional Version) - Addition for the Implementation of Rapid Detection of Clusters (Populations) of Patients - |
February 6, 2020 | Guidelines for Active Epidemiological Investigation in Patients with Novel Coronavirus Infection (Tentative Version) |
The novel coronavirus (hereinafter, SARS-CoV-2) is a new type of coronavirus that has been detected in patients with pneumonia of unknown cause, which has occurred in Wuhan City, Hubei Province in the People's Republic of China since December 2019. On February 11, the World Health Organization (WHO) specified the official name for the novel coronavirus infection as “COVID-19 (coronavirus disease 2019)” (hereinafter referred to as “COVID-19”). This paper summarizes and reports the results of an active epidemiological surveillance forcases of human-to-human infection of COVID-19 in 3 persons with no travel history to Wuhan for 2 weeks before the onset of the disease, in cooperation with local governments.
Read more: Case of First Human-to-Human Infection of Novel Coronavirus in Japan
Please refer to Field Brief: Diamond Princess COVID-19 Cases (https://www.niid.go.jp/niid/en/2019-ncov-e/9407-covid-dp-fe-01.html).
The initial quarantine period for those onboard the Diamond Princess was 5-19 February, with passengers informed that the 14-day quarantine could be extended if they were exposed to additional risk, for example close contact with a confirmed COVID-19 case. Additional details on quarantine measures can be found in “Field Briefing: Diamond Princess COVID-19”.
Criteria for disembarkation of non-cases from the Diamond Princess included 1) completion of a 14-day period without sharing a cabin with a confirmed case; 2) a negative result for a SARS-CoV-2 by PCR in the final days of the period; and 3) no relevant symptoms identified during a medical screening in the final day of the period. As of 20 February, over 1600 individuals have been disembarked from the Diamond Princess. Initially, testing focused on high-risk persons. Beginning on 11 Feb, efforts shifted toward testing all passengers by PCR for SARS-CoV-2. Due to the number of persons on board, these efforts began with passengers over 80, then over 75, then over 70, etc. After all passengers had been tested, the focus shifted to testing all crew members. Although no international guidelines require PCR testing to clear a quarantine for COVID-19 outbreaks, the Japanese government sought to do so as an additional measure of assurance.
In addition the data collection methods described in Field Brief: Diamond Princess COVID-19 Cases; retrospective data collection has also begun by gathering information from the ship’s onboard clinic. Data here have been analysed descriptively.
As of 20 February, 619 cases have been confirmed (16.7 % of the population on board), including 82 crew and 537 passengers. A total 3011 respiratory specimens were tested, and 621 were positive (20.6%), including double tests. Persons aboard between 70 and 89 were the most affected (Table 1). Among confirmed COVID-19 cases with recorded symptom onset (n=197), there were 34 (17.3 %) with onset dates before 6 February, which was the first full day of quarantine, and 163 (82.7%) with onset dates on or after the 6th (Figure 1). Among these 197 cases, 163 occurred during the quarantine period (48 crew, 115 passengers), with 52–92 among passengers in cabins without a previously confirmed case (Table 2). Of these, 3–7 occurred after the median quarantine day (day 7). The proportion of COVID-19 cases confirmed among passengers increased with cabin occupancy (Figure 2). A total 318 (51%) of all confirmed cases were asymptomatic when the respiratory specimen was collected (10 crew and 308 passengers).
Based on current available epidemiologic information, there is clear evidence that substantial transmission of SARS-CoV-2 was occurring prior to arrival of Diamond Princess in Yokohama. The subsequent decline in the number of confirmed cases with reported onset dates, may be explained by the natural course of the outbreak, by the implementation of quarantine measures, or by other unknown factors. Based on the cabin occupancy findings and the number of cases identified in cabins with previously confirmed cases, passengers within cabins may have been exposed to a common source or may have transmitted the virus within cabins. Due to the nature of the ship, individual isolation of all those aboard was not possible. Sharing cabins was necessary, and some crew had to perform essential duties while passengers remained aboard. After accounting for delayed reporting, the peak number of confirmed cases with known onset dates occurred on 7 February. The high number of recently reported cases can be explained by the shift in testing strategy described above, most of which were asymptomatic.
The proportion of asymptomatic cases observed aboard Diamond Princess is substantially higher than what has been reported elsewhere. A major factor in this proportion is the systematic testing of passengers that began on 11 Feb and increased each day. Due to the lack of symptom presentation, it is not possible to infer when these cases were infected (see Annex A). Some may have been secondary cases within a given cabin. Some may have been infected before the quarantine began. Nevertheless, these asymptomatic cases were detected through testing, disembarked, and transferred to isolation. Their cabin mates have been defined as close contacts with their 14-day isolation reset on the last day the asymptomatic case disembarked. The systematic testing of asymptomatic cases was therefore important and beneficial for identifying potentially infectious individuals before allowing them to disembark. Current global research has scant evidence on asymptomatic transmission of SARS-CoV-2; thus, ongoing efforts to thoroughly investigate asymptomatic cases from Diamond Princess will provide important information for the global COVID-19 outbreak. (Information on the development of symptoms after disembarkation of asymptomatic confirmed cases is being collected.)
Surveillance staff are working on merging the data from Diamond Princess with information from reported COVID-19 cases in the National Epidemiological Surveillance of Infectious Diseases (NESID) to understand more about the clinical presentation, severity and initial asymptomatic presentation. This information will be important for further the understanding this event and the global situation of COVID-19.
Nearly all disembarked individuals have observed a 14-day quarantine without sharing a cabin with a confirmed case, have received a recent negative PCR-test, and have passed a medical screening for symptoms (e.g. fever, cough,). Individuals who shared a cabin with a confirmed case will be put in isolation until they complete a 14-day beginning after the last day of contact with a confirmed COVID-19 cabinmate. This includes a large proportion of the crew, who admirably performed essential tasks that allowed the quarantine to occur and should be appreciated for their service. As more than 1600 individuals, primarily passengers, have been disembarked from Diamond Princess, the focus and support will now shift toward preventing further transmission of SARS-CoV-2 among crew.
Although the disembarked persons have passed laboratory testing, medical screening and the 14-day quarantine, they are asked to stay at home, where feasible, 14 days unless absolutely necessary, as an additional precautionary measure. They are asked also to monitor themselves for symptoms and contact a a healthcare facility if symptoms develop.
Note: this work would not have been possible without the important efforts of medical teams who went aboard Diamond Princess to care for passengers and crew and obtain this necessary information; the efforts of the crew to provide essential services; and the collaboration of Princess Cruises.
Table 1. Percent of persons aboard confirmed with COVID-19 by age group and symptom status at the time of specimen collection. (As of 20 February).
Age group |
Symptomatic confirmed cases (%) |
Asymptomatic confirmed cases (%) |
Total confirmed cases (%) |
Persons aboard on 5 February |
00-09 |
0(0) |
1(6) |
1(6) |
16 |
10-19 |
2(9) |
3(13) |
5(22) |
23 |
20-29 |
25(7) |
3(1) |
28(8) |
347 |
30-39 |
27(6) |
7(2) |
34(8) |
428 |
40-49 |
19(6) |
8(2) |
27(8) |
334 |
50-59 |
28(7) |
31(8) |
59(15) |
398 |
60-69 |
76(8) |
101(11) |
177(19) |
923 |
70-79 |
95(9) |
139(14) |
234(23) |
1015 |
80-89 |
27(13) |
25(12) |
52(24) |
216 |
90-99 |
2(18) |
0(0) |
2(18) |
11 |
Total |
301(8) |
318(9) |
619(17) |
3711 |
Figure 1. Number of confirmed COVID-19 cases* with reported onset dates, by onset date, aboard Diamond Princess, 6 – 20 February 2020 (n=163)
* The number of cases (n = 163) was based on the cases with available onset date reported.
Figure 2. Comparison of proportions of confirmed cases among passengers by cabin occupancy.
Table 2. Characteristics of COVID-19 Cases with reported on-set dates of 6 – 17 Feb 2020 (n=163).
Day of Quarantine |
Date of Onset (n cases) |
Crew |
Passengers |
||
Total |
In cabins with a confirmed case |
In cabins without a confirmed case |
|||
12 |
17 Feb (1) |
1 |
0 |
0 |
0 |
11 |
16 Feb (2) |
2 |
0 |
0 |
0 |
10 |
15 Feb (4) |
3 |
1 |
0 [1] |
0-1 |
9 |
14 Feb (7) |
5 |
2 |
1 [0] |
1 |
8 |
13 Feb (17) |
8 |
9 |
4 [3] |
2-5 |
7 |
12 Feb (12) |
7 |
5 |
0 [2] |
3-5 |
6 |
11 Feb (19) |
8 |
11 |
3 [1] |
7-8 |
5 |
10 Feb (10) |
3 |
7 |
3 [1] |
3-4 |
4 |
9 Feb (24) |
5 |
19 |
6 [9] |
4-13 |
3 |
8 Feb (19) |
2 |
17 |
1 [7] |
9-16 |
2 |
7 Feb (31) |
2 |
29 |
4 [10] |
15-25 |
1 |
6 Feb (17) |
2 |
15 |
1 [6] |
9-14 |
|
Total |
48 |
115 |
23 [40] |
52-92 |
The number in brackets represents the number of additional confirmed cases in the same cabin with unknown onset date. Due to the uncertainty of knowing which case came first, the column to the far right presents a range.
Annex A. Theoretical depiction of the identification of asymptomatic cases during the quarantine period.
We would like to extend our sincere gratitude for your patience and compliance in participating in the health observation period onboard the Diamond Princess from February 5th to 19th.
We would like to reassure you, based on your negative test results for the novel coronavirus and a successful medical visit confirming that you do not the fever or respiratory symptoms associated with the disease, that it is highly unlikely that you have been infected with the new coronavirus and can return to your normal lifestyle. We recognize that there may be concern for your health from many family and friends, so we would like to offer you the following guidance and requests from the National Institute of Infectious Diseases:
If you feel unwell during the next two weeks, please reach out for a consultation with the two institutes listed below:
In addition, as you have been carefully monitoring your health for the last two weeks, we would like to encourage you to continue with your usual disease prevention methods. This includes washing your hands often and wearing a mask.
We recognize that the recently disembarked passengers have been in the frontlines in the fight to prevent the invasion of emerging infectious diseases into Japan. We would like to request Japanese citizens for their maximum support in helping disembarked passengers regain their health and normal lifestyles.
February 21, 2020
National Institute of Infectious Diseases, Japan